Abstract
Leishmania spp. infection outcomes are dependent on both host and parasite factors. Manipulation of host signaling pathways involved in the generation of immune responses is thought to be one of the most common mechanisms used by parasites for persistence within the host. Considering the diversity of pathologies caused by different Leishmania spp., it is plausible that significant differences may exist in the mechanisms of host cell manipulation by each parasite species, which may have implications when developing new vaccine or treatment strategies. Here we show that in L. braziliensis-infection in BALB/c mice, a model of resistance, activation of ERK1/2 coincides with the peak of inflammatory responses and resolution of tissue parasitism. In contrast, in the susceptibility model of L. amazonensis-infection, an early silent phase of infection is observed, detected solely by quantification of parasite loads. At this early stage, only basal levels of P-ERK1/2 are observed. Later, after a brief shutdown of ERK1/2 phosphorylation, disease progression is observed and is associated with increased inflammation, lesion size and tissue parasitism. Moreover, the short-term down-regulation of ERK1/2 activation affected significantly downstream inflammatory pathways and adaptive T cell responses. Administration of U0126, a MEK/ERK inhibitor, confirmed this phenomenon, since bigger lesions and higher parasite loads were seen in infected mice that received U0126. To investigate how kinetics of ERK1/2 activation could affect the disease progression, U0126 was administered to L. amazonensis-infected animals earlier than the P-ERK1/2 switch off time-point. This intervention resulted in anticipation of the same effects on inflammatory responses and susceptibility phenotype seen in the natural course of infection. Additionally, in vitro inhibition of ERK1/2 affected the phagocytosis of L. amazonensis by BMDMs. Collectively, our findings reveal distinct temporal patterns of activation of inflammatory responses in L. braziliensis and L. amazonensis in the same animal background and a pivotal role for a brief and specific shutdown of ERK1/2 activation at late stages of L. amazonensis infection. Since activation of inflammatory responses is a crucial aspect for the control of infectious processes, these findings may be important for the search of new and specific strategies of vaccines and treatment for tegumentary leishmaniasis.
Highlights
Parasites of the genus Leishmania are dimorphic protozoa that are transmitted to humans or other mammalian hosts by the bite of a phlebotominae sand fly [1]
L. braziliensis infection in BALB/c mice have been considered a model of cure and resolution of lesions, while infection by L. amazonensis is associated with the development of progressive lesions and failure to resolve infection
Mice inoculated with L. braziliensis developed discrete lesions that are self-healing while mice infected with L. amazonensis were unable to control lesion development (Figure 1A)
Summary
Parasites of the genus Leishmania are dimorphic protozoa that are transmitted to humans or other mammalian hosts by the bite of a phlebotominae sand fly [1]. American tegumentary leishmaniasis (ATL) comprises some of the main clinical manifestations associated with infections by different species of Leishmania. Leishmania braziliensis is one of the most prevalent etiologic agents of ATL and may lead to CL, which is characterized by skin ulcers, usually localized at the site of the sand fly bite and mucosal leishmaniasis (ML), a severe form of TL which affects mucosa of the nose, throat and mouth. Parasites of the Leishmania mexicana complex, including Leishmania amazonensis may cause these ATL forms, in addition to diffuse cutaneous leishmaniasis (DCL), which is associated with disseminated non-ulcerative lesions, anergic immune responses and huge numbers of parasites in lesions [2]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.